Jul 04, 2026
By Transpire Insight
Description
According to a research report published by Transpire Insight, The Global Dual-energy X-ray Absorptiometry Market Size is projected to Grow from USD 1.65 Billion in 2026 to USD 5.67 Billion by 2035, at a CAGR of 11.24% during the forecast period 2026-2035. The Dual-energy X-ray Absorptiometry (DEXA) Market involves medical imaging equipment that makes use of low-dose X-rays to measure the bone mineral density (BMD) in patients, determine the risks of osteoporosis, conduct body composition analysis, and perform fracture risk assessment. DEXA imaging equipment is extensively utilized in hospitals, diagnostic imaging centers, orthopedic clinics, and research organizations for the diagnosis of osteoporosis, bone health management, and body fat and muscle mass analysis.
Introduction
The DEXA or Dual-energy X-ray Absorptiometry (DEXA) Market is witnessing steady growth owing to the increasing incidences of osteoporosis, aging population worldwide, increasing awareness regarding preventive healthcare, and high demand for early detection of bone disease. The improvement in imaging technology, artificial intelligence in diagnostic software, and body composition analysis through the use of DEXA scanners is improving the performance of DEXA scanners. Moreover, the growing healthcare infrastructure, increasing reimbursements in developed countries, and the usage of DEXA scanners in sports medicine, obesity care, and clinical research will positively impact the DEXA market during the forecast period.
Recent Development News
May 2025: SimonMed introduced its DEXA + TBS screening program, integrating bone density and bone quality to help diagnose and determine fractures from osteoporosis.
Stay Ahead of Emerging Opportunities with Expert Market Insights by Transpire Insight
The insights that have been shared through this blog are based on intensive market research carried out by Transpire Insight, an advisor that works with many global organizations. Thanks to the analysis of extensive data, forecasts made by our specialists, and industry intelligence, our reports allow clients to find strategic growth opportunities in dynamically developing industries. For all those who would like to get more detailed information regarding market segmentation, competitive analysis, regional outlooks, and future investment tendencies, there is no doubt that our full report will be of great value.
Download the exclusive Dual-energy X-ray Absorptiometry Market sample report today to uncover expert insights, emerging trends, and the opportunities defining the future of the industry.
Dual-energy X-ray Absorptiometry (DEXA) Market Size & Statistics
Regional Growth and Demand Analysis by Transpire Insight:
The region that dominates the Dual-Energy X-Ray Absorptiometry (DEXA) Market is North America, with a global market share of around 42%. The dominance of the region is attributed to the prevalence of osteoporosis and osteopenia, aging population, strong healthcare infrastructure, and extensive use of advanced diagnostic imaging devices. Effective reimbursement policies, bone mineral density screening, and good knowledge about preventative healthcare are other factors that favor the use of DEXA systems in this region. In addition, the presence of prominent medical imaging companies, technological advances, and investments in digital health and diagnostics make North America a leader in the market.
It is anticipated that the Asia-Pacific region will grow at a faster pace over the forecast period, owing to the increased elderly population, osteoporosis cases, improved healthcare infrastructure, healthcare spending, and adoption of diagnostic imaging in countries like China, Japan, India, and South Korea.
Top 15 Trends in the Dual-energy X-ray Absorptiometry (DEXA) Market
Proceed to Checkout to purchase the exclusive Dual-energy X-ray Absorptiometry Market report and gain instant access to in-depth market intelligence, strategic analysis, and future growth opportunities.
1. Increasing Adoption of AI-Enabled Bone Density Analysis
Artificial intelligence is transforming the DEXA market by improving the accuracy of bone mineral density measurements, automating image interpretation, and enhancing fracture risk prediction. AI-powered software helps clinicians detect osteoporosis earlier while reducing diagnostic variability and improving workflow efficiency.
2. Growing Demand for Early Osteoporosis Screening
The rising prevalence of osteoporosis and an aging global population are increasing the demand for early bone health assessments. Governments and healthcare organizations are promoting routine DEXA screening to enable timely diagnosis, reduce fracture risks, and improve long-term patient outcomes.
3. Expansion of Body Composition Analysis Applications
DEXA systems are increasingly being used beyond bone density testing to analyze body composition, including body fat percentage, lean muscle mass, and visceral fat. This trend is expanding the technology's use in obesity management, sports medicine, clinical nutrition, and metabolic health monitoring.
4. Development of Portable and Compact DEXA Systems
Manufacturers are introducing compact and portable DEXA scanners that require less installation space and improve accessibility in outpatient clinics, diagnostic centers, and community healthcare facilities. These systems enable broader access to bone health screening while maintaining high diagnostic accuracy.
5. Rising Integration of Cloud-Based Imaging Software
Cloud-enabled DEXA platforms are improving healthcare workflows by enabling secure image storage, remote access, real-time data sharing, and seamless integration with hospital information systems. These capabilities support telemedicine initiatives and enhance collaboration among healthcare professionals.
6. Increasing Use in Sports Medicine and Fitness
Sports medicine clinics, fitness centers, and professional athletic organizations are increasingly adopting DEXA technology to evaluate body composition, monitor muscle development, optimize training programs, and assess injury recovery. The growing emphasis on personalized fitness and performance optimization continues to expand the market for DEXA systems beyond traditional osteoporosis diagnosis.
Top 25 Companies Leading the Dual-energy X-ray Absorptiometry (DEXA) Market
Customize the exclusive Dual-energy X-ray Absorptiometry Market report today to receive tailored insights, country-specific analysis, and business-focused market intelligence.
GE HealthCare Technologies Inc. is a leading global manufacturer of medical technology and diagnostic products based in Chicago. The firm is engaged in the manufacture of products like medical imaging, ultrasound, patient monitoring, pharmaceutical diagnostics, and digital health. The company provides some of the best DEXA systems in the Dual-Energy X-ray Absorptiometry (DEXA) Market that help in bone densitometry, diagnosing osteoporosis, fracture risk assessment, and body composition analysis.
Founded: 1994 | Headquarters: Chicago, Illinois, USA
Why It Ranks:
The company has been ranking high in the DEXA Market because of its cutting edge imaging technologies, well-developed global distribution channels, innovative bone densitometry systems, and widespread availability of its products in hospitals, diagnostic imaging centers, and research organizations.
Regional Dominance:
The company has its operations across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa regions via its global manufacturing plants, healthcare partners, and sales channels.
Product Line:
Lunar™ DEXA systems, Prodigy™ DEXA systems, iDXA bone densitometers, body composition analysis systems, osteoporosis assessment software, fracture risk assessment tools, and digital health.
Recent Development:
In 2025, GE HealthCare obtained FDA approval for the Prodigy Fuga DEXA system, which includes advanced features such as whole-body rapid scan, superior body composition measurement, and clinical workflow through the cloud.
Hologic Inc. is a multinational medical technology company based in Marlborough. The firm provides advanced technologies in diagnostic imaging, women's health, molecular diagnostics, and skeletal health solutions. Hologic leads the market in providing bone densitometry systems for the diagnosis of osteoporosis, fracture risk assessment, and body composition analysis in the DEXA Market.
Founded: 1985 | Headquarters: Marlborough, Massachusetts, USA
Why It Ranks:
Hologic ranks amongst the top firms in the DEXA Market owing to its leading-edge Horizon™ DXA platform, technological innovations in the field of skeletal health, excellent clinical research backing, and global reach.
Regional Dominance:
Global reach in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa region via vast distribution network and direct sales and healthcare partnerships.
Product Line:
Horizon™ DXA systems, Discovery™ DXA systems, body composition analysis solutions, osteoporosis assessment software, TBS compatible imaging solutions, fracture risk assessment tools, and skeletal health management software.
Recent Development:
In 2025, Hologic entered into collaboration with International Osteoporosis Foundation (IOF) for expanding the application of the AI-based Horizon™ DXA system in fracture liaison services in Europe and Asia-Pacific.
The Fujifilm Holdings Corporation is a Japanese multinational corporation dealing in technologies and healthcare. The corporation's major activities include medical imaging, healthcare IT, life sciences, electronic materials, and imaging technologies. As regards the DEXA Market, the corporation is known for developing innovative digital imaging technologies and diagnostic tools useful for bone health assessment, osteoporosis screening, and imaging procedures.
Founded: 1934 | Headquarters: Tokyo, Japan
Why It Ranks:
Being one of the leading corporations in the DEXA Market, the company is known for its high competence in diagnostic imaging, innovation in digital technologies, distribution across the world, and the wide variety of medical imaging solutions.
Regional Dominance:
Presence in Asia-Pacific, North America, Europe, Latin America, and the Middle East & Africa via global manufacturing facilities, R&D centers, and healthcare partnerships.
Product Line:
Digital radiography, DEXA compatible diagnostic imaging solutions, healthcare IT platform, medical imaging software, PACS, diagnostic X-ray system, radiology integrated solutions.
Recent Development:
Fujifilm in 2025 increased the range of its digital healthcare products through innovations in AI enabled diagnostic imaging software and integrated radiology solutions.
Swissray Global Healthcare Holding Ltd. is a medical imaging technology firm with headquarters located at Hochdorf. The firm focuses on digital radiography and bone densitometry systems, manufacturing cutting-edge DEXA systems for osteoporosis diagnosis, bone mineral density measurements, and body composition analysis. Its products are commonly used in hospitals, diagnostic imaging facilities, orthopedic clinics, and research facilities.
Founded: 1998 | Headquarters: Hochdorf, Lucerne, Switzerland
Why It Ranks:
Swissray is among the top firms within the Dual-energy X-ray Absorptiometry (DEXA) Market, which can be attributed to its bone densitometry expertise, innovative imaging technologies, user-friendly diagnostic software, and its presence within the global bone health diagnostics industry.
Regional Dominance:
Presence within Europe, North America, Asia-Pacific, Latin America, and Middle East & Africa regions via international distributors and healthcare partnerships.
Product Line:
DEXA bone densitometry systems, bone mineral density (BMD) analyzers, body composition analysis systems, osteoporosis screening systems, digital radiography systems, and diagnostic imaging software.
Recent Development:
In 2025, Swissray further developed its DEXA imaging portfolio by developing new bone densitometry software, new body composition analysis capabilities, and international distributors network to help hospitals and diagnostic centers with advanced osteoporosis diagnosis solutions.
OsteoSys Co., Ltd. is a South Korean manufacturer of medical devices based in Seoul. It manufactures technologies for bone densitometry and diagnostics with an emphasis on Dual-energy X-ray Absorptiometry (DEXA) systems for osteoporosis diagnosis, bone mineral density (BMD) measurements, and body composition analysis. Its products find applications in hospitals, orthopedic clinics, diagnostic centers, and research institutes around the world.
Founded: 2000 | Headquarters: Seoul, South Korea
Why It Ranks:
OsteoSys holds one of the leading positions in the Dual-energy X-ray Absorptiometry (DEXA) due to its expertise in bone densitometry, advanced DEXA technology, competitive product range, and growing global distribution network.
Regional Dominance:
Growing footprint in Asia-Pacific, Europe, North America, Middle East, and Latin America thanks to international distributors and collaboration with healthcare facilities.
Product Line:
Central DEXA bone densitometers, peripheral DEXA scanners, bone mineral density (BMD) analyzers, body composition analysis systems, osteoporosis screening systems, and bone health diagnostic software.
Recent Development:
In 2025, OsteoSys reinforced its position in the field of DEXA by developing imaging software, increasing speed and accuracy of scanning, and global expansion of its bone densitometry systems range.
DMS Imaging is a French medical imaging solutions provider operating out of Gallargues-le-Montueux. The firm offers digital radiology, mobile imaging technology, and DEXA solutions for assessing bone mineral density, diagnosing osteoporosis, and analyzing body composition.
Founded: 1987 | Headquarters: Gallargues-le-Montueux, Occitanie, France
Why It Ranks:
DMS Imaging is among the top firms competing in the Dual-energy X-ray Absorptiometry (DEXA) Market owing to the company's extensive experience in bone densitometry, state-of-the-art imaging technologies, strong presence in Europe, and a wide portfolio of imaging solutions.
Regional Dominance:
A strong presence in Europe, North America, Asia-Pacific, the Middle East, Africa, and Latin America through its extensive network of distributors and healthcare organizations.
Product Line:
STRATOS™ DEXA bone densitometers, central DEXA systems, bone mineral density (BMD) analyzer, body composition analysis system, osteoporosis diagnostic software, digital radiography systems, and imaging workflow solutions.
Recent Development:
In 2025, DMS Imaging made its STRATOS™ DEXA solution even more advanced by making software updates that improve image acquisition, enhance body composition analysis, and facilitate seamless integration into clinical workflow for better osteoporosis diagnosis and bone health evaluation.
BeamMed Ltd. is a med-tech firm in Israel offering a range of bone health diagnosis products from its headquarters located in Tel Aviv. The firm offers advanced Dual-energy X-ray Absorptiometry (DEXA) technology and ultrasound-based bone densitometry technology products for osteoporosis screening, bone mineral density (BMD) tests, and fracture risk analysis. The products are offered globally in hospitals, clinics, and diagnostic centers.
Founded: 2001 | Headquarters: Tel Aviv, Israel
Why It Ranks:
BeamMed is one of the top companies in the Dual-energy X-ray Absorptiometry (DEXA) Market because of the focus on bone health diagnosis, advanced screening technologies, small and portable diagnostic systems, and growing international distribution network.
Regional Dominance:
Globally distributed throughout Europe, North America, Asia-Pacific, Latin America, and the Middle East through international distributors and healthcare collaborations.
Product Line:
DEXA bone densitometry systems, ultrasound bone densitometer, BMD analyzer, osteoporosis screening equipment, fracture risk evaluation solutions, and bone health diagnostic solutions.
Recent Development:
In 2025, BeamMed further strengthened its bone health diagnosis product range by developing the capabilities of its DEXA and osteoporosis screening solutions.
Medilink is a medical equipment producer, with its headquarters located in Shenzhen. This company offers diagnostic imaging and healthcare equipment such as DEXA systems that allow measuring bone mineral density (BMD), osteoporosis screening, and body composition.
Founded: 2003 | Headquarters: Shenzhen, Guangdong, China
Why It Ranks:
Medilink is one of the top companies in the Dual-energy X-ray Absorptiometry (DEXA) Market due to its efficient bone densitometry solutions, widespread international distribution channel, and development of affordable diagnostic imaging technologies for healthcare facilities.
Regional Dominance:
Presence in the Asian Pacific, the Middle East, Africa, Latin America, and some European countries through distributors and OEM partners.
Product Line:
Bone densitometers DEXA, bone mineral density (BMD) analyzers, body composition analysis systems, osteoporosis screening devices, digital X-ray systems, diagnostic imaging software.
Recent Development:
In 2025, Medilink further developed its bone densitometry offering by upgrading the imaging software of DEXA systems, increasing their diagnostic capabilities, and reinforcing its international distribution network.
Diagnostic Medical Systems (DMS) Group is a French company that provides imaging solutions in the field of medicine. The organization develops and produces diagnostic imaging systems, including DEXA, digital radiography, and mobile imaging equipment. These systems are often used in hospitals, diagnostic imaging centers, orthopedics centers, and research facilities.
Founded: 1987 | Headquarters: Gallargues-le-Montueux, Occitanie, France
Why It Ranks:
DMS Group is one of the leaders in the DEXA Market thanks to its specialization in bone densitometry, innovations in the diagnostic imaging industry, and wide presence on European and international healthcare marketplaces.
Regional Dominance:
Widespread throughout Europe, North America, Asia-Pacific, Middle East, Africa, and Latin America via the distribution network and healthcare partners.
Product Line:
STRATOS™ DEXA bone densitometers, BMD systems, body composition analysis systems, osteoporosis diagnostics software, digital radiography systems, mobile X-ray systems, and medical imaging workflow solutions.
Recent Development:
In 2025, DMS Group continued to upgrade its STRATOS™ DEXA products via software updates that increase scanning speed, body composition analysis capabilities, and effectiveness of workflow, expanding its global distribution network to accommodate increased demand for osteoporosis screenings and skeletal health assessments.
Shenzhen XRAY Electric Co., Ltd. is a manufacturing company for medical imaging equipment located in Shenzhen. The firm offers digital X-ray systems, Dual-energy X-ray Absorptiometry (DEXA) bone densitometers, portable imaging equipment, and radiological diagnostic systems for use in hospitals, diagnostic centers, and clinics across the globe.
Founded: 2009 | Headquarters: Shenzhen, Guangdong, China
Why It Ranks:
Shenzhen XRAY Electric is one of the top companies in the Dual-energy X-ray Absorptiometry (DEXA) Market owing to its wide array of cost-efficient imaging systems, product innovations, and growing international presence in bone health diagnostics and digital radiography.
Regional Dominance:
Prominent presence in the regions of Asia-Pacific, Middle East, Africa, Latin America, and some parts of Europe through its global distribution channels and OEM arrangements.
Product Line:
DEXA bone densitometer, bone mineral density (BMD) analyzer, digital radiography (DR) system, portable X-ray machine, mobile X-ray system, medical imaging software, and diagnostic imaging equipment.
Recent Development:
In 2025, Shenzhen XRAY Electric expanded its imaging diagnostics offerings by improving the features of its DEXA systems such as imaging software, fast scanning, and digital workflow.
Schedule a meeting with our market experts to discuss the exclusive Dual-energy X-ray Absorptiometry Market report and identify the best research solution for your organization.
Conclusion
There are steady growth trends for the Dual-energy X-ray Absorptiometry (DEXA) Market that are fueled by the rise in the number of people suffering from osteoporosis disease, the aging population, and rising demand for body composition testing and diagnosis of bone health. Technology innovations like artificial intelligence, low dose technology, cloud technology, and body composition software development have enhanced the accuracy and performance of DEXA scanners. The key players like GE HealthCare Technologies, Hologic, Fujifilm Holdings, Swissray Global Healthcare, OsteoSys, DMS Imaging, BeamMed, Medilink, Diagnostic Medical Systems Group, and Shenzhen XRAY Electric are still investing in innovations, global expansion, and integration with the digital healthcare industry. With the expansion of preventive care programs and osteoporosis screening programs, the market is set for steady long-term growth in hospitals, diagnostic imaging centers, orthopedics centers, and research facilities.
Send us a brief description of your challenge and we'll get back to you within 24 hours.
inquiry@transpireinsight.com
APAC:+91 7666513636
Address
